COMPANY NEWS

June 18, 2025

June 18, 2025

CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study

Frontiers in Veterinary Science paper reports rapid, significant pain relief with weekly p62-plasmid injections and no significant side-effects
Do you like it?
Read more
November 14, 2024

November 14, 2024

CureLab Oncology Seeks to Revolutionize Chronic Pain Management with Novel p62-Based Therapy

Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for millions
Do you like it?
Read more
October 16, 2024

October 16, 2024

CureLab CEO Dr. Alexander Shneider Unveils Promising Cancer Treatment at 2024 MedInvest Conference

Do you like it?
Read more
September 23, 2024

September 23, 2024

CureLab Veterinary Announces $15 Million Regulation D Offering to Advance Cancer and Inflammatory Disease Treatments for Pets

Clinical-stage pre-IPO biotech company is leveraging translational science to extend the healthy lives of beloved companions; this offering is limited to accredited investors.
Do you like it?
Read more
1234
© 2026 CureLab Veterinary